34
Problems of Polypharmacy Dr Nivi Singh Elderly Care Department

Problems of Polypharmacy

  • Upload
    vashon

  • View
    141

  • Download
    5

Embed Size (px)

DESCRIPTION

Problems of Polypharmacy. Dr Nivi Singh Elderly Care Department. Definition. Multiple drug use by patients 4 or more medications. Elderly. Medication use increases with age Over 60s - 19% of the population 57% of dispensed prescriptions Over 70s - 20% taking > 5 medications. Causes. - PowerPoint PPT Presentation

Citation preview

Page 1: Problems of Polypharmacy

Problems of Polypharmacy

Dr Nivi Singh

Elderly Care Department

Page 2: Problems of Polypharmacy

Definition

• Multiple drug use by patients

• 4 or more medications

Page 3: Problems of Polypharmacy

Elderly

• Medication use increases with age

• Over 60s - 19% of the population

• 57% of dispensed prescriptions

• Over 70s - 20% taking > 5 medications

Page 4: Problems of Polypharmacy

Causes

• Appropriate

• Inappropriate

Page 5: Problems of Polypharmacy

Appropriate

• Multiple medical problems

• New drugs for previously untreatable dx

• Proof of efficacy of treatment in elderly

Page 6: Problems of Polypharmacy

Usually/always Inappropriate

Multiple drug prescribers• Direct relationship btn the number of prescribing

physicians and the incidence of ADRs• Non-medical prescribing

No regular medication review

Prescribing cascade

Prescribing of drugs that are not indicated

Page 7: Problems of Polypharmacy

Patient factors

• Inaccurate drug history

• Underreporting of symptoms

• Hoarding medications

• Reluctance to discontinue medication

Page 8: Problems of Polypharmacy

Associations

• Adverse drug reactions

• Reduced compliance - > 2daily doses or >3 different drugs

• Poor quality of life

• High rate of symtomatology

• Hospital admission

• Longer length of stay

Page 9: Problems of Polypharmacy

Associations

• Increased mortality

• Readmission on discharge

• Drug expense

Page 10: Problems of Polypharmacy

Adverse Drug Reaction

A response to a drug that is:

noxious and unintended

occurs in doses normally used for the

treatment, prophylaxis, or diagnosis of

disease, or the modification of physiological function (WHO)

Page 11: Problems of Polypharmacy

ADRs

• Increase morbidity and mortality

• Underestimated

• Implicated in ~17% hospital admissions

• ~30% of elderly pts exposed to drugs that may interact with one another

Page 12: Problems of Polypharmacy

ADRs

The most consistent risk factor for an ADR is:

Number of drugs being taken

ADR rate 1.2% with 1 drug

10% with 9 drugs

50% with 10 drugs

Page 13: Problems of Polypharmacy
Page 14: Problems of Polypharmacy

Mechanisms of altered drug response in the elderly

Page 15: Problems of Polypharmacy

Changes with age

Altered drug pharmacokinetics• changes in absorption, distribution,

metabolism and excretion

Altered drug pharmacodynamics• altered tissue sensitivity

Page 16: Problems of Polypharmacy

Volume of Distribution

• Increased % of body fat

• Reduced lean body mass

• Reduced total body water (15%)

Page 17: Problems of Polypharmacy

Changes in protein binding

Decrease in plasma proteins

• reduced protein bound (inactive) drug • greater amount of free (active) drug • increased drug effect, potentially

resulting in toxicity

Page 18: Problems of Polypharmacy

Metabolism

• Reduction in hepatic blood-flow and mass

• Hepatic clearance of many drugs is reduced

• Care - drugs with a narrow therapeutic range that are metabolised by the liver (eg. warfarin, phenytoin, theophylline)

Page 19: Problems of Polypharmacy

Excretion

• Fall in GFR and creatinine clearance

• Reduces elimination of many drugs

• Care - narrow therapeutic range drugs eliminated partially or totally by the kidney (eg. digoxin, lithium and aminoglycoside antibiotics)

Page 20: Problems of Polypharmacy

Pharmacodynamics

• Changes occur in end-organ responsiveness to medications

• Due to alterations in receptors and homeostatic mechanisms

• e.g. an increased receptor response is seen for benzodiazepines, opiates, and warfarin

• Increased likelihood of an ADR

Page 21: Problems of Polypharmacy

Drugs that commonly produce adverse effects in elderly

Page 22: Problems of Polypharmacy

Categories of medication

Medication Category

Cardiovascular

% enrollees

53

Antibiotics 45

Diuretics 30

Opioids 22

Non-opioid analgesics 20

Antidepressants 13

Sedatives and hypnotics

Anticoagulants

13

7

Page 23: Problems of Polypharmacy

Recognising ADRs

• Constipation• Confusion• Dizziness• Depression• Incontinence• Nausea• Unsteadiness

Page 24: Problems of Polypharmacy

Falls

Increased risk of falls

• Polypharmacy is a marker of underlying comorbidity

• High risk medications

Page 25: Problems of Polypharmacy

Benefits of reducing polypharmacy

• Reduced ADRs

• Improved compliance

• Improved patient quality of life

• Reduced hospital admissions

• Lower risk of drug interactions

• Fewer drug errors

• Reduced prescribing costs

Page 26: Problems of Polypharmacy

NSF

• Gain the max benefit from their medication to increase their quality and duration of life

• Avoid excessive, inappropriate, or inadequate consumption of medicines

Page 27: Problems of Polypharmacy

Solutions

Page 28: Problems of Polypharmacy

Basic principles of good prescribing

• Accurate diagnosis

• Non-pharmacological agent

• Start with lowest dose – Start low; Go slow

• Consider potential side-effects and their impact

• Review entire medication regimen

Page 29: Problems of Polypharmacy

Regular medication review

• >4 medications 6-monthly review

• < 4 medications annual review

• Full drug history

• Over-the-counter medication

• Alternative drug therapies

Page 30: Problems of Polypharmacy

Alternative drug therapies

• Gingko, garlic and ginseng – all interact with warfarin and possibly aspirin

• Alcohol - exacerbates drug-induced hypotension or sedation

• Many commonly prescribed medications have the potential to interact with alcohol

Page 31: Problems of Polypharmacy

Medication Review

• Identify unnecessary drugs

• Review dose

• Once daily / once weekly formulations

Page 32: Problems of Polypharmacy

Medication Review

• Non-pharmacological interventions

• Enlist family/friends as needed

• Medication organisation equipment

• Variety of healthcare professionals

• Information technology

Page 33: Problems of Polypharmacy

Patient Education

• Written information

• Take drugs as prescribed

• Do not use medication from others

• Report symptoms

• Report all drugs used

Page 34: Problems of Polypharmacy

Conclusion

• Common and growing problem

• Inappropriate and appropriate prescribing

• Benefits of reducing the drug burden

• Regular medication review

• Not always avoidable –minimise unnecessary multiple drugs